- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06367478
Evaluation of Nerve Conduction Study (SPEMG)
April 11, 2024 updated by: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Evaluation of Acquisition Parameters and Stimulation to Obtain Different Neurophysiological Responses
the investigators study different modality to obtain nerve evoked reponses.
They use different parameters of acquisition and stimulation and they compare amplitude and latency of nerve conduction response
Study Overview
Status
Active, not recruiting
Conditions
Study Type
Observational
Enrollment (Actual)
125
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Milan, Italy, 20122
- Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico of Milan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Probability Sample
Study Population
healthy subjects
Description
Inclusion Criteria:
- absence of previous nervous pathologies
Exclusion Criteria:
- nerve disease
- diabetes
- polyneuropathy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
best amplitude of nerve conduction study
Time Frame: baseline and after 30 minutes
|
baseline and after 30 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2021
Primary Completion (Actual)
October 22, 2021
Study Completion (Estimated)
October 22, 2024
Study Registration Dates
First Submitted
March 29, 2024
First Submitted That Met QC Criteria
April 11, 2024
First Posted (Actual)
April 16, 2024
Study Record Updates
Last Update Posted (Actual)
April 16, 2024
Last Update Submitted That Met QC Criteria
April 11, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- SPEMG
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Health, Subjective
-
Chulalongkorn UniversityNot yet recruiting
-
Prince Sattam Bin Abdulaziz UniversityCompletedHealth, SubjectiveSaudi Arabia
-
Çankırı Karatekin UniversityCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineCompleted
-
Hebrew SeniorLifeCompletedHealth, Subjective
-
Istanbul University - Cerrahpasa (IUC)Not yet recruiting
-
Bahçeşehir UniversityNot yet recruiting
-
BMI KoreaCompletedHealth, SubjectiveKorea, Republic of
-
Alteogen, Inc.CompletedHealth, SubjectiveKorea, Republic of
-
Tel Aviv UniversityCompletedHealth, SubjectiveIsrael